Morocco's Milestone in Medical Cannabis Export
In a groundbreaking development for the pharmaceutical sector, Morocco has officially exported its first GMP-certified pharmaceutical cannabis extract. This significant milestone marks a pivotal moment in the country's endeavors to establish a structured and ambitious medical cannabis industry. The extract, derived from the local Beldia variety, has been exported by Cannaflex and Sothema, two leading players in the Moroccan pharmaceutical and legal cannabis sectors, demonstrating the nation’s commitment to harnessing the potential of medical cannabis.
Significance of GMP Certification
The GMP certification, an abbreviation for Good Manufacturing Practices, is a crucial benchmark that signifies the quality assurance of pharmaceutical products. It ensures that the manufacturing process complies with stringent international standards, thereby affirming the product’s safety, efficacy, and quality. The export of this cannabis extract not only showcases Morocco's advancements in the medical cannabis field but also positions the country as a competitive player on the global stage of pharmaceutical exports. This initiative highlights Morocco's dedication to developing a robust legal cannabis industry while contributing to the global dialogue on medicinal cannabis usage.
As reported by lematin.ma.
